Table 2 Village-by-village participation proportion and prevalence of infection in 50 villages of Samar Province, the Philippines, 2003–2004.
Village | No. of Participants | No. of individuals with at least one stool sample (% of total no. of participants) | Proportion with light infection (1–100 epg) with 95% Bayesian credible interval | Proportion with moderate to heavy infection (>100 epg) with 95% Bayesian credible interval |
|---|---|---|---|---|
24 | 114 | 98 (86.0%) | 0.0% (0. 0%–3.1%) | 0.0% (0.0%–0.0%) |
26 | 164 | 141 (86.0%) | 0.7% (0. 0%–2.8%) | 0.0% (0.0%–0.0%) |
2 | 162 | 113 (69.8%) | 0.9% (0. 0%–4.4%) | 0.0% (0.0%–0.0%) |
15 | 152 | 103 (67.8%) | 1.9% (0. 0%–7.8%) | 0.0% (0.0%–1.0%) |
25 | 168 | 149 (88.7%) | 2.0% (0.7%–4.7%) | 0.0% (0.0%–0.7%) |
18 | 173 | 121 (69.9%) | 2.5% (0.8%–6.6%) | 0.0% (0.0%–0.8%) |
11 | 154 | 119 (77.3%) | 3.4% (0.8%–8.4%) | 0.8% (0.0%–1.7%) |
49 | 164 | 142 (86.6%) | 3.5% (0.7%–7.8%) | 0.0% (0.0%–0.7%) |
13 | 161 | 125 (77.6%) | 4.0% (0.8%–9.6%) | 1.6% (0.8%–2.4%) |
39 | 123 | 88 (71.5%) | 4.6% (1.1%–9.1%) | 0.0% (0.0%–1.1%) |
22 | 177 | 151 (85.3%) | 6.6% (2.7%–10.6%) | 0.0% (0.0%–1.3%) |
29 | 168 | 143 (85.1%) | 7.0% (3.5%–12.6%) | 1.4% (0.0%–2.8%) |
5 | 176 | 145 (82.4%) | 7.6% (4.1%–13.1%) | 2.1% (0.7%–3.5%) |
17 | 165 | 138 (83.6%) | 8.0% (4.4%–12.3%) | 0.0% (0.0%–0.7%) |
16 | 159 | 148 (93.1%) | 8.1% (4.1%–13.5%) | 0.0% (0.0%–1.4%) |
20 | 181 | 138 (76.2%) | 8.7% (4.4%–14.5%) | 0.0% (0.0%–1.5%) |
38 | 181 | 168 (92.8%) | 9.6% (4.8%–15.6%) | 0.0% (0.0%–1.2%) |
1 | 168 | 125 (74.4%) | 12.8% (8.8%–18.4%) | 0.0% (0.0%–1.6%) |
12 | 135 | 113 (83.7%) | 14.2% (7.1%–23.0%) | 1.8% (0.9%–3.5%) |
33 | 52 | 48 (92.3%) | 14.6% (6.3%–25.0%) | 6.3% (2.1%–10.4%) |
28 | 164 | 142 (86.6%) | 15.5% (10.6%–20.4%) | 0.7% (0.0%–2.8%) |
6 | 82 | 75 (91.5%) | 16.0% (8.0%–24.0%) | 1.3% (0.0%–2.7%) |
14 | 175 | 143 (81.7%) | 16.1% (10.5%–23.1%) | 1.4% (0.0%–2.8%) |
27 | 58 | 45 (77.6%) | 17.8% (6.7%–31.1%) | 6.7% (0.0%–11.1%) |
19 | 166 | 118 (71.1%) | 17.8% (11.0%–25.4%) | 0.9% (0.0%–3.4%) |
45 | 174 | 135 (77.6%) | 18.5% (13.3%–25.2%) | 3.0% (0.7%–5.9%) |
3 | 166 | 155 (93.4%) | 18.7% (13.6%– 5.2%) | 3.9% (2.6%–6.5%) |
35 | 162 | 128 (79.0%) | 19.5% (14.1%–27.3%) | 3.9% (1.6%–6.3%) |
7 | 101 | 73 (72.3%) | 20.6% (13.7%–30.1%) | 1.4% (1.4%–5.5%) |
8 | 92 | 67 (72.8%) | 22.4% (13.4%–32.8%) | 1.5% (0.0%–4.5%) |
21 | 179 | 133 (74.3%) | 22.6% (15.8%–30.1%) | 5.3% (2.3%–9.0%) |
32 | 150 | 135 (90.0%) | 23.0% (16.3%–30.4%) | 3.7% (2.2%–5.9%) |
41 | 166 | 143 (86.1%) | 23.1% (16.8%–30.8%) | 3.5% (1.4%–6.3%) |
40 | 91 | 77 (84.6%) | 24.7% (16.9%–33.8%) | 2.6% (0.0%–7.8%) |
4 | 168 | 128 (76.2%) | 25.0% (18.8%–33.6%) | 2.3% (0.8%–6.3%) |
34 | 168 | 138 (82.1%) | 26.8% (19.6%–34.8%) | 5.1% (3.6%–8.0%) |
9 | 121 | 98 (81.0%) | 27.6% (20.4%–36.7%) | 7.1% (4.1%–12.2%) |
46 | 54 | 50 (92.6%) | 28.0% (20.0%–38.0%) | 6.0% (2.0%–10.0%) |
50 | 178 | 147 (82.6%) | 29.3% (22.5%–37.4%) | 8.2% (4.8%–11.6%) |
42 | 123 | 93 (75.6%) | 31.2% (23.7%–39.8%) | 4.3% (1.1%–7.5%) |
23 | 164 | 104 (63.4%) | 34.6% (26.0%–44.2%) | 2.9% (1.0%–7.7%) |
30 | 73 | 61 (83.6%) | 36.1% (26.2%–47.5%) | 6.6% (1.6%–13.1%) |
31 | 41 | 38 (92.7%) | 36.8% (26.3%–52.6%) | 18.4% (10.5%–26.3%) |
47 | 155 | 131 (84.5%) | 37.4% (29.8%–45.8%) | 13.0% (8.4%–18.3%) |
37 | 171 | 151 (88.3%) | 38.4% (31.8%–45.7%) | 6.6% (4.0%–12.6%) |
44 | 176 | 146 (83.0%) | 39.0% (31.5%–46.6%) | 8.9% (4.8%–13.7%) |
36 | 56 | 45 (80.4%) | 40.0% (28.9%–55.6%) | 13.3% (6.7%–22.2%) |
48 | 36 | 33 (91.7%) | 42.4% (30.3%–57.6%) | 6.1% (3.0%–15.2%) |
10 | 82 | 61 (74.4%) | 42.6% (31.2%–54.1%) | 23.0% (16.4%–31.2%) |
43 | 128 | 115 (89.8%) | 45.2% (36.5%–53.9%) | 6.1% (1.7%–13.0%) |